# CETIRIZINE HYDROCHLORIDE ALLERGY
> **ANDA207235** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2016-08-12
## Drug
- **FDA Application Number:** ANDA207235
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CETIRIZINE HYDROCHLORIDE ALLERGY
- **Generic name:** CETIRIZINE HYDROCHLORIDE
- **Active ingredients:** CETIRIZINE HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** APOTEX
- **Manufacturer:** American Sales Company
- **First approval:** 2016-08-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207235)
---
*MORVS · CC0 1.0*